Literature DB >> 12850534

The anxiogenic beta-carboline FG-7142 inhibits locomotor exploration similarly in postweanling and adult rats.

George E Jaskiw1, Barbara K Lipska, Daniel R Weinberger.   

Abstract

The beta-carboline FG-7142 exerts many stress-like effects in the adult rat, including the inhibition of locomotor exploration. However, comparable effects in immature animals have not been reported. Stress-like effects of FG-7142 are mediated via its inverse agonist actions on gamma-aminobutyric acid (GABA) receptors. GABA systems change considerably with development and GABA agonists such as diazepam have opposite behavioral actions in immature and adult rats. Accordingly, we compared FG-7142 effects on locomotor exploration in postweanling and adult rats. Postweanling male rats (24 days) and adult rats (90 days) received a single injection of vehicle or FG-7142 (15 mg/kg i.p.) and 15 min later were placed in photocell monitors for 1 h. Although postweanling animals traveled a smaller distance overall than adults, FG-7142 inhibited locomotor exploration to a similar degree in both groups. We conclude that FG-7142 exerts stress-like effects in postweanling rats and may be considered for use as a model of childhood stress.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12850534     DOI: 10.1016/s0304-3940(03)00384-7

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  2 in total

1.  Use of the light/dark test for anxiety in adult and adolescent male rats.

Authors:  Andrew E Arrant; Nicole L Schramm-Sapyta; Cynthia M Kuhn
Journal:  Behav Brain Res       Date:  2013-05-27       Impact factor: 3.332

2.  PWZ-029, a compound with moderate inverse agonist functional selectivity at GABA(A) receptors containing alpha5 subunits, improves passive, but not active, avoidance learning in rats.

Authors:  Miroslav M Savić; Terry Clayton; Roman Furtmüller; Ivana Gavrilović; Janko Samardzić; Snezana Savić; Sigismund Huck; Werner Sieghart; James M Cook
Journal:  Brain Res       Date:  2008-02-19       Impact factor: 3.252

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.